Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Night Procedure

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effect of the night procedure in regards to colon cleansing level and capsule excretion rate.

Clinical Trial Description

The evaluation of subjects with suspected colonic disease includes endoscopic imaging by colonoscopy and radiologic imaging such as air-contrast barium enema, or CT colonography. The Given® Diagnostic System offers an alternative approach for endoscopic visualization of the colon using capsule endoscopy, an ingestible device which contains imagers, light sources, a power source and a RF transmitter. Advantages of the Given® Diagnostic System include the elimination of the need for sedation, the minimally invasive, painless nature of the exam, and the ability to pursue normal daily activities immediately following the procedure . Furthermore, compared to standard colonoscopy, the Given® Diagnostic System may be more readily accepted by the subjects, thereby improving subjects' willingness to undergo a diagnostic evaluation of the colon and comply with colorectal cancer screening recommendations.

The PillCam™ SB capsule (formerly M2A® Capsule) that was FDA-approved in August 2001 for small bowel evaluation has been ingested to date by more than 500,000 people worldwide and is well accepted by patients and physicians as well as the processional societies. However, adequate visualization of the colon cannot be achieved with the standard PillCam™ SB capsule because of the anatomical and physiological properties of the colon which are significantly different than the small bowel. Moreover, other issues that limit the evaluation of the colonic mucosa by the standard PillCam™ SB procedure include an unsatisfactory level of colon cleanliness and slow progression of the PillCam™ SB capsule through the colon during the desired examination time. Therefore, the development and introduction of a specially designed, customized colon capsule combined with a dedicated capsule colonoscopy procedure protocol will allow for more efficient evaluation of the colonic mucosa. This is expected to improve the capability of the Given® Diagnostic System to detect colonic pathologies and to serve as a diagnostic and screening tool for colonic disease. Further details of the PillCam™ Colon Capsule Endoscope (PCCE) can be found in the device description section.

This is a pilot study that is designed to evaluate the level of cleanliness and visualization of colon achieved by colon capsule endoscopy when using Night procedure regimens for preparation of the colon. ;

Study Design

Related Conditions & MeSH terms

Colonic Diseases

Clinical Trial Details

NCT number	NCT00951587
Study type	Interventional
Source	Medtronic - MITG
Contact
Status	Completed
Phase	Phase 3
Start date	February 2008
Completion date	March 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02503696` - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)	N/A
Completed	`NCT01063231` - Evaluation of PillCam™ Colon 2 in Visualization of the Colon	Phase 3
Terminated	`NCT01119027` - Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills	N/A
Completed	`NCT04074577` - Computer Aided Detection, Tandem Colonoscopy Study	N/A
Not yet recruiting	`NCT04087824` - Deep Learning Algorithm for Recognition of Colonic Segments.	N/A
Completed	`NCT03559543` - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	Phase 2
Terminated	`NCT02503631` - Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Completed	`NCT01600209` - Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing	N/A
Completed	`NCT01260168` - Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies	N/A
Completed	`NCT00604162` - PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon	Phase 3
Recruiting	`NCT04598880` - Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing	Phase 4
Completed	`NCT01738425` - A Clinical Phase I Study on GIC-1001 in Healthy Volunteers	Phase 1
Completed	`NCT04080843` - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients	Phase 2
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Completed	`NCT02291445` - Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study	Phase 2
Completed	`NCT03037385` - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors	Phase 1/Phase 2
Completed	`NCT03139942` - Optical Polyp Testing for In Vivo Classification	N/A
Completed	`NCT04263818` - Endoscopist and Endoscope Motions During Colonoscopy	N/A
Recruiting	`NCT05923918` - A Study to Evaluate Safety and Efficacy of PBK_M2101	Phase 3
Completed	`NCT02647866` - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis	Phase 2